Item 2.02. Results of Operations and Financial Condition.

The following information, including Exhibit 99.1, is being "furnished" in accordance with General Instruction B.2. of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

On May 10, 2023, VolitionRx Limited (the "Company") issued a press release announcing its financial results and certain business updates for the quarter ended March 31, 2023. The Company also confirmed its conference call to be held on May 11, 2023 at 8:30 a.m. U.S. Eastern Time. Furnished herewith as Exhibit 99.1 and incorporated by reference herein is a copy of the press release.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits.



Exhibit
Number     Description
  99.1       Press Release of VolitionRx Limited, dated May 10, 2023.
104        Cover Page Interactive Data File (embedded within the Inline XBRL
           (eXtensible Business Reporting Language) document)





2

© Edgar Online, source Glimpses